BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9548915)

  • 1. Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan.
    Somoza JR; Skillman AG; Munagala NR; Oshiro CM; Knegtel RM; Mpoke S; Fletterick RJ; Kuntz ID; Wang CC
    Biochemistry; 1998 Apr; 37(16):5344-8. PubMed ID: 9548915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state kinetics of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus: the role of threonine-47.
    Munagala NR; Chin MS; Wang CC
    Biochemistry; 1998 Mar; 37(12):4045-51. PubMed ID: 9521725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
    Munagala NR; Wang CC
    Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of selective submicromolar inhibitors of Tritrichomonas foetus hypoxanthine-guanine-xanthine phosphoribosyltransferase.
    Aronov AM; Munagala NR; Ortiz De Montellano PR; Kuntz ID; Wang CC
    Biochemistry; 2000 Apr; 39(16):4684-91. PubMed ID: 10769124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus.
    Somoza JR; Chin MS; Focia PJ; Wang CC; Fletterick RJ
    Biochemistry; 1996 Jun; 35(22):7032-40. PubMed ID: 8679528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus has unique properties.
    Beck JT; Wang CC
    Mol Biochem Parasitol; 1993 Aug; 60(2):187-94. PubMed ID: 8232411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxanthine-guanine phosphoribosyltransferase as a therapeutic target in protozoal infections.
    Ullman B; Carter D
    Infect Agents Dis; 1995 Mar; 4(1):29-40. PubMed ID: 7728354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a bacterial screen for novel hypoxanthine-guanine phosphoribosyltransferase substrates.
    Shivashankar K; Subbayya IN; Balaram H
    J Mol Microbiol Biotechnol; 2001 Oct; 3(4):557-62. PubMed ID: 11545274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor.
    Shi W; Li CM; Tyler PC; Furneaux RH; Cahill SM; Girvin ME; Grubmeyer C; Schramm VL; Almo SC
    Biochemistry; 1999 Aug; 38(31):9872-80. PubMed ID: 10433693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.
    Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW
    J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, sequencing and expression of the gene encoding hypoxanthine-guanine-xanthine phosphoribosyltransferase of Tritrichomonas foetus.
    Chin MS; Wang CC
    Mol Biochem Parasitol; 1994 Feb; 63(2):221-9. PubMed ID: 8008020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding substrate specificity in human and parasite phosphoribosyltransferases through calculation and experiment.
    Pitera JW; Munagala NR; Wang CC; Kollman PA
    Biochemistry; 1999 Aug; 38(32):10298-306. PubMed ID: 10441123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of Tritrichomonas foetus and Schistosoma mansoni purine phosphoribosyltransferases by arginine-specific reagents.
    Kanaani J; Maltby D; Somoza JR; Wang CC
    Eur J Biochem; 1997 Mar; 244(3):810-7. PubMed ID: 9108251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine metabolism of human glioblastoma in vivo.
    Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
    Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutations in the guanine phosphoribosyltransferase from Giardia lamblia modulate pyrophosphate binding and enzyme catalysis.
    Page JP; Munagala NR; Wang CC
    Eur J Biochem; 1999 Feb; 259(3):565-71. PubMed ID: 10092838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tritrichomonas foetus: a strategy for structure-based inhibitor design of a protozoan inosine-5'-monophosphate dehydrogenase.
    Luecke H; Prosise GL; Whitby FG
    Exp Parasitol; 1997 Nov; 87(3):203-11. PubMed ID: 9371085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxanthine, guanine, xanthine phosphoribosyltransferase activity in Cryptosporidium parvum.
    Doyle PS; Kanaani J; Wang CC
    Exp Parasitol; 1998 May; 89(1):9-15. PubMed ID: 9603483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents.
    Krečmerová M; Dračínský M; Hocková D; Holý A; Keough DT; Guddat LW
    Bioorg Med Chem; 2012 Feb; 20(3):1222-30. PubMed ID: 22249123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of Thermoanaerobacter tengcongensis hypoxanthine-guanine phosphoribosyl transferase L160I mutant--insights into inhibitor design.
    Chen Q; You D; Liang Y; Su X; Gu X; Luo M; Zheng X
    FEBS J; 2007 Sep; 274(17):4408-15. PubMed ID: 17662107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.